D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$642M |
| 2 |
Boeing
BA
|
+$429M |
| 3 |
Alibaba
BABA
|
+$313M |
| 4 |
Advanced Micro Devices
AMD
|
+$304M |
| 5 |
JD.com
JD
|
+$275M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.13B |
| 2 |
Amazon
AMZN
|
+$456M |
| 3 |
Procter & Gamble
PG
|
+$359M |
| 4 |
JPMorgan Chase
JPM
|
+$304M |
| 5 |
Costco
COST
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.37% |
| 2 | Consumer Discretionary | 12.29% |
| 3 | Healthcare | 8.61% |
| 4 | Financials | 6.39% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Cenovus Energy
CVE
$51.6B
| $2.49M | ﹤0.01% |
638,690
+153,680
| +32% | +$705K |
|
2127
PUT
Innovative Industrial Properties
IIPR
$1.76B
| $2.48M | ﹤0.01% |
20,000
| – | – |
|
2128
CALL
Credicorp
BAP
$30.9B
| $2.48M | ﹤0.01% |
+20,000
| New | +$2.57M |
|
2129
PUT
Danaher
DHR
$140B
| $2.48M | ﹤0.01% |
12,972
+1,692
| +15% | +$301K |
|
2130
CALL
Nucor
NUE
$60.5B
| $2.48M | ﹤0.01% |
55,200
-60,000
| -52% | -$2.66M |
|
2131
Mercury Insurance
MCY
$6.07B
| $2.47M | ﹤0.01% |
59,698
-74,825
| -56% | -$3.21M |
|
2132
PUT
Xerox
XRX
$360M
| $2.47M | ﹤0.01% |
131,500
+42,000
| +47% | +$736K |
|
|
FLXN
2133
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $2.47M | ﹤0.01% |
237,010
-466,669
| -66% | -$5.72M |
|
2134
PUT
Revolve Group
RVLV
$1.92B
| $2.46M | ﹤0.01% |
150,000
-80,000
| -35% | -$1.44M |
|
|
DGNR.U
2135
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
| $2.45M | ﹤0.01% |
+200,000
| New | +$2.37M |
|
|
ADMS
2136
DELISTED
Adamas Pharmaceuticals
ADMS
| $2.45M | ﹤0.01% |
593,947
+409,847
| +223% | +$1.59M |
|
2137
CALL
Skyworks Solutions
SWKS
$9.73B
| $2.44M | ﹤0.01% |
16,800
-3,000
| -15% | -$417K |
|
2138
CALL
Viatris
VTRS
$20.8B
| $2.44M | ﹤0.01% |
164,700
+25,000
| +18% | +$399K |
|
2139
CALL
Nutanix
NTNX
$16B
| $2.44M | ﹤0.01% |
110,000
+69,000
| +168% | +$1.58M |
|
2140
PUT
Stanley Black & Decker
SWK
$14.6B
| $2.43M | ﹤0.01% |
15,000
| – | – |
|
|
FIRY
2141
Firy Inc
FIRY
$154M
| $2.43M | ﹤0.01% |
+10,000
| New | +$2.3M |
|
2142
CALL
Zoetis
ZTS
$32.5B
| $2.43M | ﹤0.01% |
14,700
| – | – |
|
|
OCFT
2143
DELISTED
OneConnect Financial Technology
OCFT
| $2.43M | ﹤0.01% |
+11,397
| New | +$2.47M |
|
2144
Prologis
PLD
$137B
| $2.42M | ﹤0.01% |
24,094
+12,831
| +114% | +$1.29M |
|
2145
PUT
Tandem Diabetes Care
TNDM
$1.22B
| $2.42M | ﹤0.01% |
+21,300
| New | +$2.24M |
|
|
DNKN
2146
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $2.42M | ﹤0.01% |
29,500
| – | – |
|
2147
CALL
Centene
CNC
$31.6B
| $2.42M | ﹤0.01% |
41,400
-39,800
| -49% | -$2.47M |
|
2148
Mettler-Toledo International
MTD
$28.1B
| $2.41M | ﹤0.01% |
2,500
-14,915
| -86% | -$13.8M |
|
|
PENG
2149
Penguin Solutions Inc
PENG
$2.47B
| $2.41M | ﹤0.01% |
176,588
-95,546
| -35% | -$1.28M |
|
2150
Westlake Corp
WLK
$9.25B
| $2.41M | ﹤0.01% |
38,093
+33,028
| +652% | +$1.95M |
|
Similar funds
D.E. Shaw & Co's Q3 2020 Portfolio in Review
As of Q3 2020, D.E. Shaw & Co held 4,373 positions worth $97.7B, up 16% from $83.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q3 2020 filing shows 420 new, 1,314 increased, 1,591 reduced and 597 closed positions. Its largest new stake was iShares Gold Trust: 6,019,847 shares worth $217M. The largest sale was Apple, an estimated $1.13B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2020 buy was iShares Gold Trust: 6,019,847 shares worth $217M.
- D.E. Shaw & Co added most to Walt Disney in Q3 2020, an estimated $642M increase.
- D.E. Shaw & Co's biggest Q3 2020 reduction was Apple, cutting an estimated $1.13B.
- D.E. Shaw & Co fully exited American Airlines Group in Q3 2020, selling an estimated $106M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $97.7B portfolio in Q3 2020.
- D.E. Shaw & Co opened 420 new positions and closed 597 in Q3 2020.
- D.E. Shaw & Co's portfolio value rose 16% quarter-over-quarter to $97.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2020, filed 16 Nov 2020.